文献
J-GLOBAL ID:201202231608185126
整理番号:12A0823025
プロリルカルボキシペプチターゼ抑制剤の新しいクラス、パート1:発見および評価
A new class of prolylcarboxypeptidase inhibitors, Part 1: Discovery and evaluation
著者 (25件):
GRAHAM Thomas H.
(Dep. of Medicinal Chemistry, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
LIU Wensheng
(Dep. of Medicinal Chemistry, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
VERRAS Andreas
(Dep. of Medicinal Chemistry, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
SEBHAT Iyassu K.
(Dep. of Medicinal Chemistry, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
XIONG Yusheng
(Dep. of Medicinal Chemistry, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
BLEASBY Kelly
(Dep. of Drug Metabolism, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
BHATT Urmi R.
(Dep. of Metabolic Disorders, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
CHEN Qing
(Dep. of Drug Metabolism, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
GARCIA-CALVO Margarita
(Dep. of Metabolic Disorders, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
GEISSLER Wayne M.
(Dep. of Metabolic Disorders, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
GORSKI Judith N.
(Dep. of In Vivo Pharmacology, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
HE Huaibing
(Dep. of Drug Metabolism, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
LASSMAN Michael E.
(Dep. of Metabolic Disorders, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
LISNOCK Jeanmarie
(Dep. of Metabolic Disorders, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
LI Xiaohua
(Dep. of Drug Metabolism, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
SHEN Zhu
(Dep. of Metabolic Disorders, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
TONG Xinchun
(Dep. of Drug Metabolism, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
TUNG Elaine C.
(Dep. of Drug Metabolism, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
WILTSIE Judyann
(Dep. of Metabolic Disorders, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
XIAO Jianying
(Dep. of In Vivo Pharmacology, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
XIE Dan
(Dep. of Metabolic Disorders, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
XU Suoyu
(Dep. of Drug Metabolism, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
HALE Jeffrey J.
(Dep. of Medicinal Chemistry, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
PINTO Shirly
(Dep. of Metabolic Disorders, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
,
SHEN Dong-ming
(Dep. of Medicinal Chemistry, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
資料名:
Bioorganic & Medicinal Chemistry Letters
(Bioorganic & Medicinal Chemistry Letters)
巻:
22
号:
8
ページ:
2811-2817
発行年:
2012年04月15日
JST資料番号:
W0248A
ISSN:
0960-894X
資料種別:
逐次刊行物 (A)
発行国:
オランダ (NLD)
言語:
英語 (EN)